Fulgent Genetics, Inc. (FLGT) vs SOPHiA GENETICS S.A. (SOPH)

A side-by-side comparison of Fulgent Genetics, Inc. and SOPHiA GENETICS S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FLGT vs SOPH

growth of $100 · dividends reinvested · last 5y
FLGT -73.3% (-23.2%/yr)SOPH -51.1% (-13.3%/yr)SOPH compounded faster over this window
50100Start $10020222023202420252026$27$49
FLGT SOPH

FLGT vs SOPH: by the numbers

  • •SOPH is the larger company ($620M vs $582M market cap).
  • •Both run net losses; FLGT's is the smaller (-26.05% vs -93.86% net margin).
  • •SOPH grew revenue faster over the past five years (20.33% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricFLGTSOPH
P/S ratio1.807.20
P/B ratio0.587.46

Profitability

MetricFLGTSOPH
Gross margin35.58%66.63%
Operating margin-28.23%-85.01%
Net margin-26.05%-93.86%
ROE-8.42%-97.31%
ROIC-11.80%-49.73%

Growth (annualized)

MetricFLGTSOPH
Revenue CAGR (5Y)-18.66%20.33%
Total return CAGR (5Y)-22.38%-13.62%

Frequently asked

Which has grown faster, FLGT or SOPH?
Over the past five years, SOPH grew revenue faster — FLGT at a -18.66% CAGR versus SOPH at 20.33%.
How have FLGT and SOPH total returns compared?
Over the past 5 years, FLGT delivered -22.38% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.